California’s Office of Health Care Affordability faces a herculean task in its plan to slow runaway health care spending.
I-Mab and BMS to assess givastomig regimen for gastric cancers
Givastomig in combination with nivolumab plus chemotherapy will be evaluated for advanced gastric and oesophageal cancers. Credit: crystal light / Shutterstock. I-Mab has announced a